A 105-Study Review Looks at High-Power Laser for Pain and the Limits of the Evidence

By: Alena Wiese

A September 2026 meta-analysis reported large pain reductions with Class IV laser therapy across 105 studies. For Winter Garden and Horizon West residents drawn to drug-free pain care, the findings are encouraging, and the authorship, study quality, and regulatory details deserve equal attention.

A person in Horizon West may have built a whole routine around feeling better without more pills: a morning walk, a standing desk, a shelf of supplements, a foam roller parked by the couch. When a knee or shoulder still aches after all of that, the next search tends to be for something that sounds just as clean. Laser therapy, marketed as painless and drug-free, often lands near the top of the list.

So does it work? The newest research suggests high-power laser therapy was associated with meaningful pain reduction in many small trials, but the evidence has real gaps, and a laser session is no substitute for finding out what is actually causing the pain.

On Sept. 14, 2026, Frontiers in Integrative Neuroscience published a systematic review and meta-analysis of Class IV high-intensity laser therapy, often shortened to HILT. The authors pooled 105 studies published from 2018 to April 2026, covering 2,710 people in laser groups and 2,925 in comparison groups. They reported large drops in pain scores at the end of treatment, at follow-ups under three months, and at three months or later, with standardized mean differences of -0.98, -1.18, and -1.01, and no serious adverse events.

What Is Class IV Laser Therapy, In Plain Terms?

Class IV laser therapy is a high-power form of photobiomodulation, the use of red or near-infrared light to influence how cells in muscles, tendons and joints behave. The older “cold” or low-level lasers run at 0.5 watts or less, according to the definitions in the new review. The Class IV devices in the pooled trials averaged 9.3 watts, and the authors describe them as typically running at about 100 times the power of low-level units.

That power gap is the authors’ central argument: they write that low-level lasers have generally failed in trials for deeper tissue problems because too little light reaches the target.

A separate mini review published Aug. 18, 2026, in Frontiers in Pain Research adds a caution. Its authors concluded that wavelength alone does not decide how pain responds, and that the route of exposure, the tissue being targeted, the dose, the timing, and a person’s baseline pain state all matter.

Source: Mechanisms and clinical application of photobiomodulation in pain therapy: a mini review, Frontiers in Pain Research, August 2026.

What Did The New Laser Review Actually Find?

The review found that laser groups reported less pain than comparison groups in every included randomized trial of the knee (27 studies), the spine and neuromuscular conditions (20) and the shoulder and arm (20), with more than 90 percent of those trials showing large effect sizes.

Function moved too. Range of motion improved in 92 percent of the 26 studies that measured it, functional performance in 84 percent of 57 studies, and quality of life in 85 percent of 25 studies. In 13 head-to-head trials, high-intensity laser produced greater pain reduction than low-level laser in all 13.

Their conclusion is strong: Class IV laser “appears effective and safe” for durable pain reduction in deep-tissue musculoskeletal conditions, deserving coverage by payers. They also call for further multicenter trials.

Source: The importance of power in photobiomodulation: a systematic review and meta-analysis of high-intensity laser therapy, Frontiers in Integrative Neuroscience, September 2026.

What Does This Review Not Tell Us?

The review does not tell a reader who is most likely to benefit, which settings suit a given condition, or whether laser adds much beyond exercise and time.

Who wrote it? One of the two authors is listed with Aspen Lasers, LLC, a laser company in Lindon, Utah. The other is listed with Personalized Health Research Services, LLC, in Winter Park, Florida. Industry involvement does not make a finding wrong, but it is a reason to look for independent confirmation.

How different the studies were. The authors report heterogeneity (I-squared) of 90 percent among knee studies and 92 percent among shoulder and arm studies. Numbers that high mean the pooled trials differed a great deal in patients, devices, doses and comparisons, so one summary figure blends very different experiments.

How “effective” was defined. Interventions were classed as effective when they showed large effect sizes. Large effects in many small trials often shrink when larger, better-blinded trials are run.

What was missing. Many trials did not report spot size, which kept the authors from calculating power density in some studies. The review also lists benefits for conditions such as COVID-19, obesity, and endometriosis based on only a handful of studies, and those should be read as early signals, not settled findings.

What the FDA has and has not said. The review itself notes that the FDA recognized clearance for Class IV therapy lasers only as recently as 2003. Clearance is not the same as approval, and it is not a federal finding that a device treats any particular disease.

Why Is Drug-Free Pain Care Drawing So Much Interest?

Chronic pain is common enough that many households are living with it. The CDC’s National Center for Health Statistics reported that 24.3 percent of U.S. adults had chronic pain in 2023, and 8.5 percent had pain that frequently limited life or work activities. Prevalence rose with age, from 12.3 percent of adults 18 to 29 to 36.0 percent of those 65 and older.

That matters in a fast-growing corner of West Orange County. U.S. Census Bureau estimates put Winter Garden at 48,063 residents as of July 2025, with 13.8 percent age 65 or older. With young families, weekend athletes, and long commutes in the mix, the appeal of care that does not revolve around a prescription is easy to understand. The wellness instinct works best with the same skepticism people bring to a supplement label.

Source: Chronic Pain and High-impact Chronic Pain in U.S. Adults, 2023, CDC National Center for Health Statistics, November 2024.

Where Does A Local Clinic Fit Into A Careful Approach?

A careful approach starts with an evaluation, not a device. ReliefNow® Disc Joint & Nerve Center Hamlin, at 5736 Hamlin Groves Trail, Suite 154, in Winter Garden (407-706-4944), serves Hamlin, Horizon West, Winter Garden, and Windermere. Its listed services include Class IV laser therapy alongside DRX9000 spinal decompression, Knee-on-Trac knee decompression, and PRP regenerative support, and the clinic states that every plan starts with an evaluation.

Dr. Jeffrey N. Shebovsky, DC, who founded Orange Wellness in 1994, brings more than 30 years of clinical experience and holds Florida chiropractic license CH6499.

In practice, that evaluation sorts people into groups. Conservative care, which may include laser as one part of a plan, is generally considered for musculoskeletal pain without warning signs. Some symptoms call for medical or emergency care first: back pain with fever, unexplained weight loss, new bowel or bladder changes, progressive leg weakness or numbness, chest pain or shortness of breath, or pain after a serious fall or crash.

Progress should be measured, not guessed: pain scores, range of motion, and specific tasks such as stairs, recorded at the start and at set intervals. If those numbers stall, the plan should change.

How Should A Wellness-Minded Person Weigh Laser Therapy?

A reasonable reading of the new review is that high-power laser therapy has a growing body of mostly small, positive trials behind it, written up here by authors who make a strong case for it. That is worth pairing with the questions a careful shopper would ask anywhere: what is my diagnosis, what will be measured, and what else in my routine, from strength work to sleep, is part of getting better.

Drug-free care and evidence-based care can be the same thing. The new research shows how much careful reading that still takes.

Dr. Jeffrey N. Shebovsky, DC | ReliefNow® Disc Joint & Nerve Center Hamlin | 5736 Hamlin Groves Trail, Suite 154, Winter Garden, FL 34787 | 407-706-4944 |

Disclaimer: This article is for informational and educational purposes only and is not intended to provide medical advice, diagnosis, or treatment. Consult a qualified healthcare provider before beginning any treatment program.